Neurology III
Seven topics, 38 cases — choose one below to browse its cases.
Spinal muscular atrophy therapy selection, neurofibromatosis, tuberous sclerosis, mitochondrial disease, Pompe disease, cerebral ALD, and Rett syndrome pharmacotherapy
Atypical parkinsonism, autonomic pharmacotherapy in MSA, primary progressive aphasia, normal pressure hydrocephalus, and psychosis in Parkinson's disease dementia
CGRP monoclonal antibodies and gepants, onabotulinumtoxinA, pediatric migraine, medication overuse headache, diabetic peripheral neuropathy, trigeminal neuralgia, and cluster headache pharmacotherapy
Psychiatric symptoms caused by neurological disease: pseudobulbar affect, post-stroke depression prophylaxis, anti-NMDA receptor encephalitis, and emotional incontinence after TBI
Empiric treatment before confirmation: HSV encephalitis, bacterial meningitis, botulism antitoxin, suspected PML in natalizumab, and toxoplasmosis vs. lymphoma in advanced HIV
Acute TBI/SCI pharmacology: seizure prophylaxis agent selection, progesterone's negative trial history, and high-dose methylprednisolone's contested NASCIS legacy
Corticosteroid decisions in neuro-ophthalmologic and otologic disease: optic neuritis (ONTT), idiopathic intracranial hypertension (IIHTT), and sudden sensorineural hearing loss